Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
32.14
+0.73 (2.32%)
Oct 30, 2025, 10:14 AM EDT - Market open

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022
Period Ending
Dec '23 Dec '22
Antisense Oligonucleotide
8.78M
Log In
Antisense Oligonucleotide Growth
-29.22%
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022
Period Ending
Dec '23 Dec '22
United States
8.78M
Log In
United States Growth
-29.22%
Log In